Updated Jul 16, 2026 · Last SEC filing 2026-07-14
ANI PHARMACEUTICALS INC (ANIP) has filed 15 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-14. 3 Form 8-K material event filings were reported by ANIP in the last 90 days. 6 Form 144 notices of proposed sale were filed for ANIP stock. InsiderAlpha tracks every ANIP SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001023024 |
| Form 4 filings (90d) | 15 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 6 |
| Latest Form 4 filing | 2026-07-14 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S — Open-market sale [10b5-1] | 500 | $81.84 | $41K | SEC | |
| CAREY STEPHEN P. | SVP & CFO | S — Open-market sale | 3.3K | $86.00 | $285K | SEC | |
| CAREY STEPHEN P. | SVP & CFO | M — Option exercise | 3.3K | $49.51 | $164K | SEC | |
| CAREY STEPHEN P. | SVP & CFO | S — Open-market sale | 2.9K | $84.12 | $240K | SEC | |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S — Open-market sale | 500 | $82.03 | $41K | SEC | |
| HAUGHEY THOMAS | Director | S — Open-market sale | 2.0K | $80.88 | $162K | SEC | |
| CAREY STEPHEN P. | SVP & CFO | S — Open-market sale | 3.3K | $80.00 | $265K | SEC | |
| CAREY STEPHEN P. | SVP & CFO | M — Option exercise | 3.3K | $49.51 | $164K | SEC | |
| Leonard Matthew J | Director | A — Grant or award | 4.4K | $0.00 | — | SEC | |
| Pera Antonio R | Director | A — Grant or award | 4.4K | $0.00 | — | SEC | |
| TANNENBAUM RENEE P | Director | A — Grant or award | 4.4K | $0.00 | — | SEC | |
| Thoma Jeanne | Director | A — Grant or award | 4.4K | $0.00 | — | SEC | |
| HAUGHEY THOMAS | Director | A — Grant or award | 4.4K | $0.00 | — | SEC | |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S — Open-market sale | 500 | $78.16 | $39K | SEC | |
| Walsh Patrick D | Director | S — Open-market sale | 10.0K | $80.63 | $806K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for ANI PHARMACEUTICALS INC (ANIP). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| CAREY STEPHEN P. | 7 | $1.45M |
| Cook Meredith | 3 | $121K |
| HAUGHEY THOMAS | 2 | $162K |
| Walsh Patrick D | 2 | $1.13M |
| Lalwani Nikhil | 1 | $4.27M |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ANIP insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ANIP dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.